Amelia Weber Hall

Amelia Weber Hall

Auto-generated profile, based on publicly available information

Amelia Weber Hall

Broad Institute of MIT Harvard Broad Institute of MIT Harvard

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
NTNathan R. Tucker
Nathan R. Tucker
MCMark Chaffin
Mark Chaffin
SFStephen J. Fleming
Stephen J. Fleming
AHAmelia W. Hall
Amelia W. Hall
VPVictoria A. Parsons
Victoria A. Parsons
PEPatrick T. Ellinor
Patrick T. Ellinor
Background: The human heart requires a complex ensemble of specialized cell types to perform its essential function. A greater knowledge of the intricate cellular milieu of the heart is critical to increase our understanding of cardiac homeostasis and pathology. As recent advances in low-input RNA sequencing have allowed definitions of cellular transcriptomes at single-cell resolution at scale, we have applied these approaches to assess the cellular and transcriptional diversity of the nonfailing human heart. Methods: Microfluidic encapsulation and barcoding was used to perform single nuclear RNA sequencing with samples from 7 human donors, selected for their absence of overt cardiac disease. Individual nuclear transcriptomes were then clustered based on transcriptional profiles of highly variable genes. These clusters were used as the basis for between-chamber and between-sex differential gene expression analyses and intersection with genetic and pharmacologic data. Results: We sequenced the transcriptomes of 287 269 single cardiac nuclei, revealing 9 major cell types and 20 subclusters of cell types within the human heart. Cellular subclasses include 2 distinct groups of resident macrophages, 4 endothelial subtypes, and 2 fibroblast subsets. Comparisons of cellular transcriptomes by cardiac chamber or sex reveal diversity not only in cardiomyocyte transcriptional programs but also in subtypes involved in extracellular matrix remodeling and vascularization. Using genetic association data, we identified strong enrichment for the role of cell subtypes in cardiac traits and diseases. Intersection of our data set with genes on cardiac clinical testing panels and the druggable genome reveals striking patterns of cellular specificity. Conclusions: Using large-scale single nuclei RNA sequencing, we defined the transcriptional and cellular diversity in the normal human heart. Our identification of discrete cell subtypes and differentially expressed genes within the heart will ultimately facilitate the development of new therapeutics for cardiovascular diseases.

26 November 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JPJames P. Pirruccello
James P. Pirruccello
MCMark D. Chaffin
Mark D. Chaffin
ECElizabeth L. Chou
Elizabeth L. Chou
SFStephen J. Fleming
Stephen J. Fleming
HLHonghuang Lin
Honghuang Lin
PEPatrick T. Ellinor
Patrick T. Ellinor

24 November 2008 in Aging Cell
Verified
Journal Article
Open access
PDF file
ASAndrei Seluanov
Andrei Seluanov
CHChristopher Hine
Christopher Hine
MBMichael Bozzella
Michael Bozzella
AHAmelia Hall
Amelia Hall
TSTais H. C. Sasahara
Tais H. C. Sasahara
VGVera Gorbunova
Vera Gorbunova
Summary: Large, long‐lived species experience more lifetime cell divisions and hence a greater risk of spontaneous tumor formation than smaller, short‐lived species. Large, long‐lived species are thus expected to evolve more elaborate tumor suppressor systems. In previous work, we showed that telomerase activity coevolves with body mass, but not lifespan, in rodents: telomerase activity is repressed in the somatic tissues of large rodent species but remains active in small ones. Without telomerase activity, the telomeres of replicating cells become progressively shorter until, at some critical length, cells stop dividing. Our findings therefore suggested that repression of telomerase activity mitigates the increased risk of cancer in larger‐bodied species but not necessarily longer‐lived ones. These findings imply that other tumor suppressor mechanisms must mitigate increased cancer risk in long‐lived species. Here, we examined the proliferation of fibroblasts from 15 rodent species with diverse body sizes and lifespans. We show that, consistent with repressed telomerase activity, fibroblasts from large rodents undergo replicative senescence accompanied by telomere shortening and overexpression of p16Ink4aand p21Cip1/Waf1cycline‐dependent kinase inhibitors. Interestingly, small rodents with different lifespans show a striking difference: cells from small shorter‐lived species display continuous rapid proliferation, whereas cells from small long‐lived species display continuous slow proliferation. We hypothesize that cells of small long‐lived rodents, lacking replicative senescence, have evolved alternative tumor‐suppressor mechanisms that prevent inappropriate cell divisionin vivoand slow cell growthin vitro. Thus, large‐bodied species and small but long‐lived species have evolved distinct tumor suppressor mechanisms.

17 January 2020 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SCSeung Hoan Choi
Seung Hoan Choi
SJSean Jurgens
Sean Jurgens
LWLu-Chen Weng
Lu-Chen Weng
JPJames P. Pirruccello
James P. Pirruccello
CRCarolina Roselli
Carolina Roselli
PEPatrick T. Ellinor
Patrick T. Ellinor
Rationale: Genome-wide association studies have identified over 100 genetic loci for atrial fibrillation (AF); recent work described an association between loss-of-function (LOF) variants in TTN and early-onset AF. Objective: We sought to determine the contribution of rare and common genetic variation to AF risk in the general population. Methods: The UK Biobank is a population-based study of 500 000 individuals including a subset with genome-wide genotyping and exome sequencing. In this case-control study, we included AF cases and controls of genetically determined white-European ancestry; analyses were performed using a logistic mixed-effects model adjusting for age, sex, the first 4 principal components of ancestry, empirical relationships, and case-control imbalance. An exome-wide, gene-based burden analysis was performed to examine the relationship between AF and rare, high-confidence LOF variants in genes with ≥10 LOF carriers. A polygenic risk score for AF was estimated using the LDpred algorithm. We then compared the contribution of AF polygenic risk score and LOF variants to AF risk. Results: The study included 1546 AF cases and 41 593 controls. In an analysis of 9099 genes with sufficient LOF variant carriers, a significant association between AF and rare LOF variants was observed in a single gene, TTN (odds ratio, 2.71, P =2.50×10 −8 ). The association with AF was more significant (odds ratio, 6.15, P =3.26×10 −14 ) when restricting to LOF variants located in exons highly expressed in cardiac tissue ( TTN LOF ). Overall, 0.44% of individuals carried TTN LOF variants, of whom 14% had AF. Among individuals in the highest 0.44% of the AF polygenic risk score only 9.3% had AF. In contrast, the AF polygenic risk score explained 4.7% of the variance in AF susceptibility, while TTN LOF variants only accounted for 0.2%. Conclusions: Both monogenic and polygenic factors contribute to AF risk in the general population. While rare TTN LOF variants confer a substantial AF penetrance, the additive effect of many common variants explains a larger proportion of genetic susceptibility to AF.

16 February 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DHD. Brent Halling
D. Brent Halling
BLBenjamin J. Liebeskind
Benjamin J. Liebeskind
AHAmelia W. Hall
Amelia W. Hall
RARichard W. Aldrich
Richard W. Aldrich
Significance: Calmodulin is essential for sensing intracellular Ca 2+ in eukaryotic cells. Calmodulin modulates hundreds of effectors, and it has a highly conserved protein sequence. Humans have three identical copies, but a change in either the protein sequence or the protein expression level of any one of the three copies can cause life-threatening disease. We analyzed calmodulin sequences across eukaryotes and compared biophysical properties and structures to show that all of calmodulin’s four Ca 2+ -binding sites have conserved properties that distinguish them from one another.

21 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
INIoanna Ntalla
Ioanna Ntalla
LWLu-Chen Weng
Lu-Chen Weng
JCJames H. Cartwright
James H. Cartwright
AHAmelia Weber Hall
Amelia Weber Hall
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
PMPatricia B. Munroe
Patricia B. Munroe
The electrocardiographic PR interval reflects atrioventricular conduction, and is associated with conduction abnormalities, pacemaker implantation, atrial fibrillation (AF), and cardiovascular mortality. Here we report a multi-ancestry (N = 293,051) genome-wide association meta-analysis for the PR interval, discovering 202 loci of which 141 have not previously been reported. Variants at identified loci increase the percentage of heritability explained, from 33.5% to 62.6%. We observe enrichment for cardiac muscle developmental/contractile and cytoskeletal genes, highlighting key regulation processes for atrioventricular conduction. Additionally, 8 loci not previously reported harbor genes underlying inherited arrhythmic syndromes and/or cardiomyopathies suggesting a role for these genes in cardiovascular pathology in the general population. We show that polygenic predisposition to PR interval duration is an endophenotype for cardiovascular disease, including distal conduction disease, AF, and atrioventricular pre-excitation. These findings advance our understanding of the polygenic basis of cardiac conduction, and the genetic relationship between PR interval duration and cardiovascular disease.